What laboratory tests are recommended for evaluating hypercalcemia?

Laboratory Evaluation of Hypercalcemia

The initial and most critical laboratory test for evaluating hypercalcemia is serum intact parathyroid hormone (PTH), which distinguishes PTH-dependent from PTH-independent causes and should be measured alongside serum calcium, phosphorus, and creatinine 1.

Essential Initial Laboratory Panel

When hypercalcemia is identified, order the following tests immediately:

• Serum intact PTH - This is the single most important discriminatory test 1

  • Elevated or inappropriately normal PTH (typically >20 pg/mL) = Primary hyperparathyroidism (PHPT)
  • Suppressed PTH (<20 pg/mL) = PTH-independent cause (malignancy, granulomatous disease, vitamin D toxicity, etc.)

• Serum calcium - Use albumin-adjusted or ionized calcium for accuracy 1

• Serum phosphorus - Typically low in PHPT, variable in malignancy 2

• Serum creatinine/eGFR - Essential to assess renal function and interpret PTH levels 3

• Serum albumin - Required to calculate corrected calcium if total calcium is measured 1

Second-Tier Laboratory Tests Based on PTH Results

If PTH is Elevated or Inappropriately Normal (PHPT suspected):

• 24-hour urine calcium-to-creatinine clearance ratio (CCCR) - To exclude familial hypocalciuric hypercalcemia (FHH) 3, 4

  • CCCR >0.01 rules out FHH (some use >0.02 cutoff) 4
  • Ensure vitamin D level ≥50 nmol/L before interpreting urinary calcium 4

• 25-hydroxyvitamin D - Vitamin D deficiency can elevate PTH and must be assessed 3

• Bone density scan and renal imaging - If PHPT confirmed, to evaluate for complications 3

If PTH is Suppressed (PTH-independent cause):

• PTH-related protein (PTHrP) - Elevated in humoral hypercalcemia of malignancy (HHM) 5

  • Found in 80% of cancer patients with hypercalcemia and no bone metastases 5
  • Critical caveat: Always measure PTH even in known malignancy patients, as concurrent PHPT occurs in up to 25% of cases 5

• 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D - Elevated in vitamin D intoxication or granulomatous diseases 1, 2

• Serum and urine protein electrophoresis - If multiple myeloma suspected

• Thyroid function tests - Hyperthyroidism can cause hypercalcemia 5

Algorithmic Approach to Laboratory Interpretation

1. Confirm true hypercalcemia: Measure ionized calcium or albumin-adjusted calcium
2. Measure PTH immediately: This single test narrows differential to two main pathways
3. PTH elevated/normal pathway:
   • Measure 24-hour CCCR to exclude FHH
   • Check vitamin D status
   • Proceed to imaging if PHPT confirmed
4. PTH suppressed pathway:
   • Measure PTHrP (especially if malignancy known or suspected)
   • Measure vitamin D metabolites
   • Consider additional workup based on clinical context

Critical Pitfalls to Avoid

• Do not rely solely on PTH to diagnose PHPT - Use multivariate approach including calcium, chloride, and phosphorus for 95-98% accuracy 2

• PTH assay generation matters - Use assay-specific reference ranges; both second- and third-generation assays have similar diagnostic sensitivity for PHPT 3

• Timing and sample handling affect PTH - PTH is more stable in EDTA plasma at 4°C; has circadian rhythm 3

• Biotin interference - High-dose biotin supplements can falsely alter PTH results depending on assay design 3

• Race, age, and BMI affect PTH - PTH is higher in Black individuals, increases with age, and is elevated in obesity 3

• Renal function critically affects interpretation - PTH increases as GFR declines; in end-stage renal disease, very high PTH with normal PTHrP is expected 3, 5

The combination of serum calcium, PTH, and phosphorus provides the most cost-effective and accurate diagnostic approach, achieving 95-98% accuracy in identifying the cause of hypercalcemia 2. Adding PTHrP measurement when PTH is suppressed increases diagnostic accuracy to 99%, particularly in distinguishing malignancy-related hypercalcemia 2, 5.